Monte Rosa Therapeutics, Inc.GLUENASDAQ
Loading
Income Quality Over TimeExpanding
Percentile Rank33
3Y CAGR-11.5%
5Y CAGR-1.7%
Year-over-Year Change
Quality of reported income
3Y CAGR
-11.5%/yr
Annual compound
5Y CAGR
-1.7%/yr
Recent deceleration
Percentile
P33
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.59 | +202.2% |
| 2024 | -0.58 | -278.5% |
| 2023 | 0.32 | -62.0% |
| 2022 | 0.85 | +6.2% |
| 2021 | 0.80 | +24.9% |
| 2020 | 0.64 | -19.4% |
| 2019 | 0.80 | - |